D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 93 Citations 46,826 320 World Ranking 568 National Ranking 330
Medicine D-index 96 Citations 53,984 364 World Ranking 5744 National Ranking 3166

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Internal medicine
  • Acquired immunodeficiency syndrome

His primary areas of investigation include Immunology, Acquired immunodeficiency syndrome, Virology, Virus and Internal medicine. He is involved in the study of Immunology that focuses on Immune system in particular. Robert T. Schooley has researched Acquired immunodeficiency syndrome in several fields, including Clinical research, MEDLINE, Viral disease, Intensive care medicine and Pharmacotherapy.

His Virology study integrates concerns from other disciplines, such as Cell culture, In vitro, Reverse transcriptase and Recombinant DNA. His biological study spans a wide range of topics, including Antibody, Menstrual cycle and Genitourinary system. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Surgery, AIDS-related complex and Zidovudine.

His most cited work include:

  • Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework* (4269 citations)
  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents (4138 citations)
  • The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial. (2708 citations)

What are the main themes of his work throughout his whole career to date?

Robert T. Schooley spends much of his time researching Virology, Immunology, Virus, Acquired immunodeficiency syndrome and Internal medicine. His Virology research incorporates themes from Peripheral blood mononuclear cell, Antibody and Antigen. His Immunology study frequently links to adjacent areas such as Cytotoxic T cell.

The study incorporates disciplines such as T lymphocyte and Lymphocyte in addition to Virus. In his study, MEDLINE is strongly linked to Intensive care medicine, which falls under the umbrella field of Acquired immunodeficiency syndrome. His research investigates the connection with Internal medicine and areas like Gastroenterology which intersect with concerns in Zidovudine.

He most often published in these fields:

  • Virology (42.11%)
  • Immunology (42.38%)
  • Virus (23.27%)

What were the highlights of his more recent work (between 2016-2021)?

  • Virology (42.11%)
  • Antibiotics (3.88%)
  • Internal medicine (17.73%)

In recent papers he was focusing on the following fields of study:

Robert T. Schooley mainly focuses on Virology, Antibiotics, Internal medicine, Microbiology and Phage therapy. His study in Virology is interdisciplinary in nature, drawing from both Antibody, Acquired immunodeficiency syndrome and Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019. His work on Nevirapine as part of general Acquired immunodeficiency syndrome research is frequently linked to In patient, bridging the gap between disciplines.

His research in Internal medicine intersects with topics in Raltegravir, Sarcoma and Metronidazole. Robert T. Schooley combines subjects such as Clinical trial, Intensive care medicine, Clinical microbiology, Antibiotic resistance and Bacteriophage Therapy with his study of Phage therapy. Recombinant soluble CD4 is a subfield of Immunology that Robert T. Schooley explores.

Between 2016 and 2021, his most popular works were:

  • Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection (365 citations)
  • Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus (322 citations)
  • Reducing transmission of SARS-CoV-2. (266 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Immune system

His primary areas of study are Internal medicine, Antibiotics, Microbiology, Adverse effect and 2019-20 coronavirus outbreak. His Internal medicine research includes elements of Raltegravir, Lamivudine and Etravirine. The various areas that Robert T. Schooley examines in his Microbiology study include Bilateral lung transplantation, Liver function and Lytic cycle.

His 2019-20 coronavirus outbreak research entails a greater understanding of Virology. His work carried out in the field of Virology brings together such families of science as Tumor necrosis factor alpha, Antibody and Immunity. His Bacteriophage study incorporates themes from Immunology, Bone Infection, Positive culture, Lung transplant recipient and Klebsiella pneumoniae.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*

Arthur J. Atkinson;Wayne A. Colburn;Victor G. DeGruttola;David L. DeMets.
Clinical Pharmacology & Therapeutics (2001)

6146 Citations

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.

Margaret A Fischl;D. D. Richman;M. H. Grieco;M. S. Gottlieb.
The New England Journal of Medicine (1987)

4505 Citations

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith.
Annals of Internal Medicine (1998)

4221 Citations

Chronic Fatigue Syndrome: A Working Case Definition

Gary P. Holmes;Jonathan E. Kaplan;Nelson M. Gantz;Anthony L. Komaroff.
Annals of Internal Medicine (1988)

2506 Citations

Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell.
JAMA (2000)

1382 Citations

Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome

D D Ho;T R Rota;R T Schooley;J C Kaplan.
The New England Journal of Medicine (1985)

1355 Citations

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker.
The New England Journal of Medicine (1996)

1269 Citations

Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner.
JAMA (2006)

1134 Citations

HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Bruce D. Walker;Sekhar Chakrabarti;Bernard Moss;Timothy J. Paradis.
Nature (1987)

1030 Citations

Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis

Richard J. Whitley;Charles A. Alford;Martin S. Hirsch;Robert T. Schooley.
The New England Journal of Medicine (1986)

992 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert T. Schooley

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 224

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 175

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 137

David A. Cooper

David A. Cooper

University of New South Wales

Publications: 123

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 119

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 112

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 112

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 107

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 104

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 94

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 89

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 87

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 86

Adriano Lazzarin

Adriano Lazzarin

Vita-Salute San Raffaele University

Publications: 84

Michael S. Saag

Michael S. Saag

University of Alabama at Birmingham

Publications: 81

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 77

Trending Scientists

Hassan K. Khalil

Hassan K. Khalil

Michigan State University

José Carlos Maldonado

José Carlos Maldonado

Universidade de São Paulo

David Z. Pan

David Z. Pan

The University of Texas at Austin

Georges Calas

Georges Calas

Sorbonne University

Wei Huang

Wei Huang

Northwestern Polytechnical University

Min Zhi Rong

Min Zhi Rong

Sun Yat-sen University

Uwe Ohler

Uwe Ohler

Max Delbrück Center for Molecular Medicine

Eric B. Kmiec

Eric B. Kmiec

University of Delaware

Pierre Mineau

Pierre Mineau

Environment and Climate Change Canada

Bo Riemann

Bo Riemann

Aarhus University

Eoin J. O'Gorman

Eoin J. O'Gorman

University of Essex

Atle M. Bones

Atle M. Bones

Norwegian University of Science and Technology

Michael S. Barker

Michael S. Barker

University of Arizona

J. Lee Nelson

J. Lee Nelson

Fred Hutchinson Cancer Research Center

Gerald L. Andriole

Gerald L. Andriole

Washington University in St. Louis

Grace Kao

Grace Kao

Yale University

Something went wrong. Please try again later.